https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520–%2520Goldman%2520Sachs%2520Conference%25202015.pdf
PolyOne Corporation Page 1 PolyOne Investor Presentation Goldman Sachs Basic Materials Conference May 2015 PolyOne Corporation Page 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. S&P 500 PolyOne Corporation Page 9 2006 Q1 2015 2020 “Where we were” “Where we are” Platinum Vision 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 16.2% 20%+ Global Specialty Engineered Materials 1.1% 16.3% 20%+ Designed Structures & Solutions 1.4% (2012) 2.7% 12 – 14% Performance Products & Solutions 5.5% 6.5% 10 – 12% Distribution 2.6% 5.9% 6.5 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 69% 80%+ 3) ROIC 5.0% 11.4% 15% 4) Adjusted EPS Growth N/A 22 Consecutive Quarters of EPS Growth Double Digit Expansion Proof of Performance & 2020 Goals PolyOne Corporation Page 10 Platinum Vision: Pathway to Accelerated Growth Organic Sales Growth Margin Expansion Share Repurchases Acquisitions PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2014 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 27% 2006 2014 Specialty Platform Gross Margin % 20% 44% 2006 2014 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 12 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 13 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 6 9 7 3 5 12 5 3 2 8 4 2 4 3 1 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 14 8 18 12 22 74 Addressable Market ($ millions) $700 $600 $600 $1,900 PolyOne Corporation Page 14 60% 98% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 Q1 2015 Pension Funding** As of 2015年3月31日 Debt Maturities & Pension Funding Net Debt / EBITDA* = 2.1x $49 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of 2015年3月31日 ($ millions) Coupon Rate: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2015 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return Expanding our sales, marketing, and technical capabilities Investing in operational and LSS initiatives ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend Targets that expand our: • Specialty offerings • End market presence • Geographic breadth Synergy opportunities Adjacent material solutions Repurchased over 500k shares in Q1 2015 Repurchased 11.8 million shares since early 2013 8.2 million shares are available for repurchase under the current authorization PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne? 1) Special items are a non-GAAP financial measure.
https://www.avient.com/sites/default/files/2024-12/IATF16949 2016 Certificate for PolyOne shenzhen-CN2024.pdf
1400 Ravello Drive, Katy, TX, 77449-5164, USA - TEL: +1 281-396-1000. www.dnv.com 管理体系认证证书 证书号码: 273138-2018-AQ-RGC-IATF IATF证书号码: 0558323 有效期限: 2024年12月 10日 – 2027年12月 09日 兹证明 普立万聚合体(深圳)有限公司 中国广东省深圳市宝安区沙井镇蚝乡路启航工业园1号 518104 统一社会信用代码:9144030076498189X0(USI: C5M65R) 外部支持场所:见附页 质量管理体系符合 : IATF 16949:2016 此证书对下列范围有效: 塑料改性材料的设计和制造 豁免:无 http://www.dnv.com 证书号码: 273138-2018-AQ-RGC-IATF IATF证书号码: 0558323 证书制作地点及日期: Katy, TX, 2024年12月 10日 未履行认证协议中规定条款会导致此证书失效,获证组织必须定期接受监督审核并经审核合格此证书方继续有效。获得认可的单位: DNV Business Assurance USA Inc., 1400 Ravello Drive, Katy, TX, 77449-5164, USA - TEL: +1 281-396-1000. www.dnv.com 页 2 / 2 证书附页 普立万聚合体(深圳)有限公司 外部支持场所:场所名称 场所地址 外部支持场所活动 认证机构 普立万企业管理(上海)有限公司 中国上海浦东金桥经济开发技术区 金苏路200号C幢2楼 201206(USI: PKFHC3) 产品设计,过程设计 DNV 普立万聚合体(苏州)有限公司 中国江苏省苏州工业区胜港街77号 215127(USI: CF4943) 合同评审,销售,供应商管理 DNV http://www.dnv.com
https://www.avient.com/sites/default/files/2021-10/microbial-susceptibility-of-various-polymers-and-evaluation.pdf
REFERENCES [1] S. Biotechnol. 2021, 9, 1. [27] R. Microbiol. 2019, 10, 1. [29] J.
https://www.avient.com/sites/default/files/2020-12/versaflex-portable-speaker-product-bulletin.pdf
Versaflex TPE 材料为需要持久密 封的垫圈提供了极佳的压缩永久变形性能,同时使得耐用型扬声器外壳具有了如丝般的触感。硬度 42A 65A 65A 80A 70A 颜色 自然色 自然色 自然色 自然色 自然色 包覆成型 PC/ABS, COPE PC/ABS, COPE PC/ABS, COPE PC/ABS PC/ABS 特性 低压缩永久变形 丝般触感/耐久性佳 丝般触感/适用于薄长 部件 无析出/丝般触感/耐污/ 抗紫外光 无析出/丝般触感/耐污/ 抗紫外光 应用 Versaflex™ CE 3120-40 Versaflex™ CE 3120-65 Versaflex™ CE 3620 Versaflex™ CE 3130-80 Versaflex™ CE 3130-70 表面 表面 表面 表面密封垫 ™ Versaflex TPE 如何让便携式扬声器与众不同 垫片 防水防尘 - 外壳密封紧密,可确保长期使用无泄漏 降低制造成本 - - 比硅树脂或热塑性聚氨酯(TPU )具有更快的循 环时间 设计自由 - 垫片中的注塑TPE 使得难以组装简易型O 形圈的 复杂设计成为可能 扬声器外壳 外观耐久 - 柔滑触感 - 耐磨、抗紫外线、外观持久 降低制造成本 - 直接包覆成型到基板上,无需采购和组装硅树脂 外壳;对聚碳酸酯和 ABS 具有很强的附着力 - 比硅树脂或热塑性聚氨酯(TPU )具有更快的循 环时间 设计自由 - TPE包覆成型,无需使用机械互锁装置和底漆即 可将硅树脂材料粘附到基板上 欲了解更多关于Versaflex™ TPE在便携式扬声器应用的信息, 请联系埃万特 +86-21-60284888 现如今,便携式扬声器制造商都在寻找可信赖的材料,在防水防尘的同时兼具耐久性并提供更多的设计可能性。我们的 Versaflex TPE 可以完全满足所有这些要求,同时提高生产速度,降低制造成本。
https://www.avient.com/sites/default/files/resources/AquaMix-_Fact_Sheet__72831-B_%25281%2529.pdf
Massillon, OH 44646 Phone: 1.330.834.3820 Fax: 1.330.837.8467 www.PolyOne.com EUROPE PolyOne Belgium SA Rue Melville Wilson 2 5330 Assesse Belgium Phone: +32 (0) 83 660 271 E-mail: info.color@polyone.com www.PolyOne.com ASIA PolyOne Shanghai China No. 88, GuoShouJing Road Z.J. We believe no competitor can match our technical expertise because no workforce can outperform the people of PolyOne. A line of casein-free dispersions is also available. 17 in 11 in 17.25 in 11.25 in CMYK P1PC-011AquamixFactSheet2.indd REMAY 72831-B Zig trim: 17.000" x 11.000" bleed: .125" Digital/IAM QC˛______ ______ Client˛_____ _____ Date ____/____/____ Proof No.4______ 25 50 100 25 50 100 25 2 2 50 100 25 2 2 50 100 Asset No. 72831-B Antioxidants Dispersions AO 2246 Aquamix 105 40 Irganox® 1010 Aquamix 327 40 Irganox® 1076 Aquamix 683 40 Wingstay® L Aquamix 125 50 Antioxidants Emulsions Wingstay® 29/SN-1 Aquamix 312 50 Wingstay® L/SN-1 Aquamix 289 50 Wingstay® L/SN-1 Aquamix 494 60 Higher concentrated version of Aquamix 289.
https://www.avient.com/news/archives?page=10
Avient Introduces Versaflex™ TF Adhesive TPEs for Textile Fabrics Wilflex™ Revive™ Inks, Created With 50-59% Bio-Derived Content, Are Available From Wilflex™ Distribution Partners Beginning March 1, 2024. March 1, 2024
https://www.avient.com/sites/default/files/resources/Wells%2520Fargo%2520Conference%2520-%2520IR%2520Presentation%25205-6-2015%2520-%2520wNon%2520GAAP%2520and%2520Appendix.pdf
PolyOne Corporation Page 1 PolyOne Investor Presentation Wells Fargo Industrial & Construction Conference May 2015 PolyOne Corporation Page 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. S&P 500 PolyOne Corporation Page 9 2006 Q1 2015 2015 Target “Where we were” “Where we are” (Est. in 2012) 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 16.2% 12 – 16% Global Specialty Engineered Materials 1.1% 16.3% 12 – 16% Designed Structures & Solutions 1.4% (2012) 2.7% 8 – 10% Performance Products & Solutions 5.5% 6.5% 9 – 12% Distribution 2.6% 5.9% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 69% 65 – 75% 3) ROIC 5.0% 11.4% 15% 4) Adjusted EPS Growth N/A 5% Double Digit Expansion Proof of Performance & 2015 Goals PolyOne Corporation Page 10 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2014 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 27% 2006 2014 Specialty Platform Gross Margin % 20% 44% 2006 2014 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 11 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) $800 $450 $450 $1,700 PolyOne Corporation Page 13 60% 98% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 Q1 2015 Pension Funding** As of 2015年3月31日 Debt Maturities & Pension Funding – 3/31/15 Net Debt / EBITDA* = 2.1x $49 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of 2015年3月31日 ($ millions) Coupon Rate: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2015 PolyOne Corporation Page 14 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return Expanding our sales, marketing, and technical capabilities Investing in operational and LSS initiatives ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend Targets that expand our: • Specialty offerings • End market presence • Geographic breadth Synergy opportunities Adjacent material solutions Repurchased over 500k shares in Q1 2015 Repurchased 11.8 million shares since early 2013 8.2 million shares are available for repurchase under the current authorization PolyOne Corporation Page 15 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 16 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne? 1) Special items are a non-GAAP financial measure.
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202018.pdf
I N V E S T O R D A Y O R L A N D O , F L O R I D A | M A Y 2 0 1 8 F O R W A R D L O O K I N G S T A T E M E N T S PolyOne Corporation 2 In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. I N V E S T O R D A Y A G E N D A M A Y 1 0 , 2 0 1 8 PolyOne Corporation 5 8:00 WELCOME BREAKFAST 9:00 Introduction: Bob Patterson 9:45 Investing for Growth: Michael Garratt Commercial Resources Innovation Service 10:15 SEGMENT REVIEWS PolyOne Distribution: Scott Horn Specialty Engineered Materials: Michael Garratt BREAK (10 MINUTES) SEGMENT REVIEWS (CONTINUED) Performance Products & Solutions: Don Wiseman Color, Additives & Inks: Mark Crist 11:40 Mergers & Acquisitions: Joel Rathbun 12:00 Financial Review: Brad Richardson 12:20 Conclusion/Q&A: Bob Patterson 1:00 LUNCH Bradley C. PolyOne Corporation 91 S P E E D T O M A R K E T From concept to production M O N T H M O N T H M O N T H M O N T H M O N T H M O N T H 99.9% Reduction in turnaround time Traditional Timeline up to 24 weeks PolyOne ColorMatrix Select™ 6 hours PolyOne Corporation 92 “Being able to create color and produce parts in 1 day is unheard of in this industry.
https://www.avient.com/resource-center?document_type=221&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=3
Enhance your cosmetic packaging with Gravi-Tech and Versaflex solutions Versaflex™ HC TPEs for IV Infusion Cap (English) Versaflex™ HC TPEs for Laryngeal Mask Airway
https://www.avient.com/resource-center?document_subtype=0&document_type=221&form_id=resource_filter_form&industry=0&op=FILTER RESULTS&product_family=0&product_name=0&page=3
Enhance your cosmetic packaging with Gravi-Tech and Versaflex solutions Versaflex™ HC TPEs for IV Infusion Cap (English) Versaflex™ HC TPEs for Laryngeal Mask Airway